Eric Benevich Neurocrine Biosciences Inc (NBIX) insider trading activity

NBIX Quotes by TradingView

Eric Benevich is Chief Commercial Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 44,689 shares of NBIX, which is worth approximately $6.34 Million. The most recent transaction as insider was on Nov 10, 2022, when has been sold 100 shares (Common Stock) at a price of $125.36 per share, resulting in proceeds of $12,536. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.7K
0% 3M change
9.59% 12M change
Total Value Held $6.34 Million

ERIC BENEVICH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 10 2022
SELL
Open market or private sale
$12,536 $125.36 p/Share
100 Reduced 0.64%
15,643 Common Stock
Nov 10 2022
BUY
Exercise of conversion of derivative security
$4,178 $41.78 p/Share
100 Added 0.63%
15,743 Common Stock
Nov 08 2022
SELL
Open market or private sale
$3,082,240 $125.33 p/Share
24,593 Reduced 61.12%
15,643 Common Stock
Nov 08 2022
BUY
Exercise of conversion of derivative security
$1,027,495 $41.78 p/Share
24,593 Added 37.94%
40,236 Common Stock
Nov 03 2022
SELL
Open market or private sale
$1,121,179 $125.02 p/Share
8,968 Reduced 36.44%
15,643 Common Stock
Nov 03 2022
BUY
Exercise of conversion of derivative security
$374,683 $41.78 p/Share
8,968 Added 26.71%
24,611 Common Stock
Nov 02 2022
SELL
Open market or private sale
$50,000 $125.0 p/Share
400 Reduced 2.49%
15,643 Common Stock
Nov 02 2022
BUY
Exercise of conversion of derivative security
$16,712 $41.78 p/Share
400 Added 2.43%
16,043 Common Stock
Oct 17 2022
SELL
Open market or private sale
$549,667 $110.82 p/Share
4,960 Reduced 24.07%
15,643 Common Stock
Feb 08 2022
SELL
Open market or private sale
$78,077 $79.67 p/Share
980 Reduced 4.6%
20,338 Common Stock
Feb 07 2022
SELL
Open market or private sale
$332,650 $80.76 p/Share
4,119 Reduced 17.47%
19,459 Common Stock
Aug 16 2021
SELL
Open market or private sale
$504,381 $89.62 p/Share
5,628 Reduced 26.5%
15,608 Common Stock
Feb 08 2021
SELL
Open market or private sale
$498,864 $116.83 p/Share
4,270 Reduced 16.83%
21,099 Common Stock
Feb 05 2021
SELL
Open market or private sale
$92,250 $114.03 p/Share
809 Reduced 4.69%
16,434 Common Stock
Jan 26 2021
SELL
Open market or private sale
$48,000 $120.0 p/Share
400 Reduced 2.48%
15,705 Common Stock
Jan 26 2021
BUY
Exercise of conversion of derivative security
$12,534 $41.78 p/Share
300 Added 1.83%
16,105 Common Stock
Jan 25 2021
SELL
Open market or private sale
$609,392 $120.03 p/Share
5,077 Reduced 24.31%
15,805 Common Stock
Jan 25 2021
BUY
Exercise of conversion of derivative security
$145,269 $41.78 p/Share
3,477 Added 14.27%
20,882 Common Stock
Nov 12 2020
SELL
Open market or private sale
$204,732 $90.71 p/Share
2,257 Reduced 11.48%
17,405 Common Stock
Nov 02 2020
SELL
Open market or private sale
$1,988,035 $96.53 p/Share
20,595 Reduced 57.26%
15,374 Common Stock
Nov 02 2020
BUY
Exercise of conversion of derivative security
$741,214 $35.99 p/Share
20,595 Added 36.41%
35,969 Common Stock

Also insider at

LIFE
aTYR PHARMA INC Healthcare
EB

Eric Benevich

Chief Commercial Officer
San Diego, CA

Track Institutional and Insider Activities on NBIX

Follow NEUROCRINE BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NBIX